首页    期刊浏览 2025年07月18日 星期五
登录注册

文章基本信息

  • 标题:Effect of Several Kinds of Drugs on the Development of Autoimmunity in MRL/Mp-lpr/lpr Mice : Lack of Correlation between the Suppression of Autoantibody Production and Prevention of Autoimmune Disease
  • 本地全文:下载
  • 作者:Masahiko MIHARA ; Yoshiyuki OHSUGI
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:1989
  • 卷号:12
  • 期号:2
  • 页码:100-106
  • DOI:10.1248/bpb1978.12.100
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:MRL/Mp-lpr/lpr (MRL/1) mice spontaneously develop autoimmune kidney disease which resembles human systemic lupus erythematosus (SLE). Employing this strain of mouse, we examined the effect of several immunosuppressants and a newly synthetized anti-nephritic agent, 4-chloro-3', 6'-dimethyl-2, 2'-iminodibenzoic acid (TO-115) on both the development of immunological abnormalities and the clinical symptoms of autoimmune kidney disease. This study aimed to determine how much the magnitude of autoantibody suppression related to the degree of prevention of autoimmune nephritis. Immunological abnormalities were assessed by measuring the serum levels of anti-deoxyribonucleic acid and anti-trinitrophenyl antibodies, rheumatoid factor (RF), and immune complex (IC). The status of autoimmune kidney disease was monitored by means of the appearance of proteinuria and survival time and the measurement of serum levels of blood urea nitrogen (BUN) and cholesterol. Immunosuppressants such as cyclophosphamide (CY), 6-mercaptopurine (6MP) and sodium aurothiomalate (SAT) remarkably suppressed the development of immunological abnormalities in a dose dependent manner. Interestingly, however, only CY showed the suppressive effect on the development of autoimmune kidney disease with prolongation of survival time and the excretion of proteinuria. In contrast, 6-MP and SAT did not inhibit the development of autoimmune kidney disease. On the other hand, TO-115 did not suppress the development of immunological abnormalities, but it restrained the symptoms of autoimmune kidney disease. Taken together, the suppression of autoantibody production does not always lead to prevention of the development of autoimmune kidney disease. It seems likely that either complete suppression of antibody production or sufficient repression of subsequent IC-induced inflammation is essential to prevent the development of autoimmune kidney disease, and to prolong the lifespan of MRL/l mice.
  • 关键词:drug treatment
国家哲学社会科学文献中心版权所有